Metraipolis › archive › dc_4e391d239e41

The Impact of Decreased GSK3β and S6K1 Expression in TNBC Patients — Europe PMC PMID:41465855

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41465855
DOI: 10.3390/life15121917
License (as archived): solo-consultazione
Archived: 2026-11-07T15:39:23.219Z
SHA-256 of the archived text: 30098ac1001a3c7ec90bc949b2ac82f9bc17a0cc68be231ce487b2fe8c6135e1
Stable URL of this page: https://metraipolis.com/documento/dc_4e391d239e41

How to cite

The Impact of Decreased GSK3β and S6K1 Expression in TNBC Patients — Europe PMC PMID:41465855 — Europe PMC (en), https://europepmc.org/article/MED/41465855 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e391d239e41 (Metraipolis archive dc_4e391d239e41, sha256 30098ac1001a3c7ec90bc949b2ac82f9bc17a0cc68be231ce487b2fe8c6135e1)

BibTeX

@misc{dc4e391d239e41,
  title = {The Impact of Decreased GSK3β and S6K1 Expression in TNBC Patients — Europe PMC PMID:41465855},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465855},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e391d239e41; sha256 30098ac1001a3c7ec90bc949b2ac82f9bc17a0cc68be231ce487b2fe8c6135e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465855. Agents can read the archived copy with the MCP tool read_document.